Correlation between free platinum AUC and total platinum measurement 24 h after i.v. bolus injection of cisplatin in humans
- 1 February 1988
- journal article
- research article
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 21 (1) , 75-77
- https://doi.org/10.1007/bf00262745
Abstract
The plasma kinetics of platinum after i.v. bolus administration of cisplatin was determined for 17 patients with advanced cancer. Statistical analysis of individual values revealed a high correlation between the area under the plasma concentration-time curve (AUC) of free platinum (unbound to proteins) and the concentration of platinum bound to plasma proteins 24 h after drug administration (Cp24). A similar correlation was found between the peak plasma values of ultrafiltrable platinum (Cp0) and Cp24. When studied in the same patient, increases in free platinum AUC and Cp0 were also found to result in increased Cp24. It is suggested that a single measurement of plasma platinum concentration 24 h after i.v. infusion of cisplatin could be a simple method either of detecting patients with extreme values of AUC and Cp0 or of studying the evolution of these parameters during multiple courses of treatment, although it cannot be used to give precise values for AUC and Cp0.This publication has 11 references indexed in Scilit:
- Anticancer drug pharmacodynamicsCancer Chemotherapy and Pharmacology, 1985
- ANTITUMOR-ACTIVITY AND TOXICITY OF SERUM PROTEIN-BOUND PLATINUM FORMED FROM CISPLATIN1985
- Cisplatin metabolites in plasma, a study of their pharmacokinetics and importance in the nephrotoxic and antitumour activity of cisplatinBiochemical Pharmacology, 1984
- In vitro interactions of TNO6 with human plasmaCancer Chemotherapy and Pharmacology, 1983
- PLASMA PLATINUM LEVELS - RELATIONSHIP TO CISPLATIN DOSE AND NEPHROTOXICITY1983
- Clinical Pharmacokinetics of Commonly Used Anticancer DrugsClinical Pharmacokinetics, 1983
- Pharmacokinetics of free platinum species following rapid, 3-hr and 24-hr infusions of cis-diamminedichloroplatinum (II) and its therapeutic implicationsEuropean Journal of Cancer and Clinical Oncology, 1982
- Pharmacokinetics and protein binding of cis-dichlorodiammine platinum (II) administered as a one hour or as a twenty hour infusionCancer Chemotherapy and Pharmacology, 1980
- Kinetics of cis‐dichlorodiammineplatinumClinical Pharmacology & Therapeutics, 1979
- Analysis of platinum in biological materials by flameless atomic absorption spectrophotometryBiochemical Medicine, 1977